在男性的卵泡刺激激素作用的药理学
Andrea Graziani1, Giuseppe Grande2, Raffele Scafa1
1Department of Medicine, University of Padova, Padova, Italy.
Andrology
|April 30, 2025
概括
对男性因子不孕症 (MFI) 的卵泡刺激激素 (FSH) 治疗显示出不同的结果. 需要考虑药物遗传学,特别是FSHB和FSHR基因多态性的个性化治疗,但需要进一步研究以获得预测准确性.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 人类遗传学 人类遗传学
- 不孕症研究 不孕症研究
背景情况:
- 男性因子不孕症 (MFI) 占夫妻不孕症病例的50%.
- 卵泡刺激激素 (FSH) 疗法在性性性性症中有效,在MFI中显示出不可预测的结果.
- 目前在MFI治疗FSH的患者选择依赖于不充分的临床和荷尔蒙评估.
研究的目的:
- 在MFI中审查FSH治疗的药物遗传学证据.
- 探索FSHB和FSHR基因多态化在预测治疗反应中的作用.
- 强调在MFI管理中需要个性化FSH治疗.
主要方法:
- 审查现有的关于FSH治疗和药物遗传学在MFI的文献.
- 对调查FSHβ子单元 (FSHB) 和FSH受体 (FSHR) 基因中的多态性研究的分析.
- 讨论有关男性FSH作用的生理和生理病理基础.
主要成果:
- 目前关于MFI中FSHB和FSHR基因多态性的证据是不确定的,并且往往是矛盾的.
- 现有研究受到小样本大小和各种终点的限制.
- 目前,FSHB和FSHR的基因评估仅用于研究目的.
结论:
- 对于MFI的FSH治疗需要个性化,考虑到个体患者的特征.
- 药物遗传因素,特别是FSHB和FSHR基因变异,可能会影响治疗反应,但需要更严格的调查.
- 需要进行更大,更全面的研究来开发FSH治疗响应者和不响应者在MFI中的预测算法.
相关概念视频
Testosterone: Functions and Regulation
348
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
348
Infertility in Males
153
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
153
Hormonal Regulation of the Menstrual Cycle
183
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
183
Factors Affecting Drug Distribution: Physiological Barriers
130
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
130
Factors Affecting Drug Biotransformation: Biological
71
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
71
Sex-linked Disorders
98.0K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
98.0K


